Lykos’ MD­MA-as­sist­ed PTSD treat­ment re­ject­ed by FDA af­ter trou­bled tri­al and push­back from ex­perts

The FDA has re­ject­ed Lykos’ MD­MA-as­sist­ed treat­ment for pa­tients with post-trau­mat­ic stress dis­or­der, a ma­jor set­back for the com­pa­ny that had hoped to trans­late more …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER